Publications by authors named "Sheldon Holder"

Claim this Profile
B
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Andre L De Souza, Matthew J Hadfield, Shaolei Lu, Dragan J Golijanin, Roxanne Wood, Sheldon L Holder

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance to molecularly targeted therapies for cancer.
Nolan M Stubbs, Tyler J Roady, Maximilian P Schwermann, Elias O Eteshola, William J MacDonald, Sheldon L Holder

Cancer Drug Resist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Innovative molecular therapeutic approaches in urothelial carcinoma.
Sheldon L Holder, Ming Yin, Monika Joshi

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of anemia and iron supplementation among glioblastoma patients reveals sex-biased association between anemia and survival.
Ganesh Shenoy, Becky Slagle-Webb, Chachrit Khunsriraksakul, Bhavyata Pandya Shesh, Jingqin Luo, Sheldon Holder

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
Monika Joshi, Leonard Tuanquin, Junjia Zhu, Vonn Walter, Todd Schell, Sheldon L Holder

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of patients with -deleted bladder cancer.
Andre L De Souza, Anthony E Mega, John Douglass, Adam J Olszewski, Ece D Gamsiz Uzun, Sheldon L Holder

Am J Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study.
Monika Joshi, Sheldon L Holder, Junjia Zhu, Hong Zheng, Shraddha Komanduri

Eur Urol Focus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patient-Level Data Meta-analysis of the Abscopal Effect.
Steven J Hatten, Eric J Lehrer, Jenn Liao, Congzhou M Sha, Daniel M Trifiletti, Sheldon L Holder

Adv Radiat Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations of DNA damage response genes correlate with response and overall survival in anti-PD-1/PD-L1-treated advanced urothelial cancer.
Monika Joshi, Petros Grivas, Amir Mortazavi, Paul Monk, Steven K Clinton, Sheldon L Holder

Cancer Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer.
Ming Yin, Petros Grivas, Qi-En Wang, Amir Mortazavi, Hamid Emamekhoo, Sheldon L Holder

Oncologist· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer.
Ming Wang, Guangqing Chi, Yosef Bodovski, Sheldon L Holder, Eugene J Lengerich

Cancer Causes Control· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for a personalized approach for muscle invasive bladder cancer: role of tumor biology in response to neoadjuvant chemotherapy.
Monika Joshi, Joshua I Warrick, Ming Yin, Sheldon L Holder, Joseph J Drabick

Transl Androl Urol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
Michael Zaleski, Augustyna Gogoj, Vonn Walter, Jay D Raman, Matthew Kaag, Sheldon Holder

Hum Pathol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.
Monika Joshi, Sherri Z Millis, David Arguello, Sheldon L Holder, Donald Lamm

Eur Urol Focus· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of abemaciclib to sunitinib induces regression of renal cell carcinoma xenograft tumors.
Jeffrey Small, Erik Washburn, Karmaine Millington, Junjia Zhu, Sheldon L Holder

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Immunotherapies for Renal Cell Carcinoma.
Mhd Yaser Al-Marrawi, Sheldon L Holder

Curr Mol Pharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and Review.
Mhd Yaser Al-Marrawi, Heath B Mackley, Suhail Ali, Henry Wagner, Monika Joshi, Sheldon Holder

Clin Genitourin Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma.
Monika Joshi, Monali Vasekar, Petros Grivas, Hamid Emamekhoo, JoAnn Hsu, Sheldon L Holder

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
Ming Yin, Monika Joshi, Richard P Meijer, Michael Glantz, Sheldon Holder

Oncologist· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review.
Ming Yin, Wenge Wang, Jennifer Rosenberg, Matthew Kaag, Monika Joshi, Sheldon Holder

Clin Genitourin Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.
Elizabeth M Matthew, Lanlan Zhou, Zhaohai Yang, David T Dicker, Sheldon L Holder

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic Secondary Polycythemia Induced by Anti-VEGF Therapy for the Treatment of Metastatic Renal Cell Carcinoma: A Case Series and Review.
Wenge Wang, Jihua Cheng, Carol Mallon, Mohammed Y Al-Marrawi, Sheldon Holder

Clin Genitourin Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.
Jacob S Lipkin, Syed M Rizvi, Zoran Gatalica, Nabeel E Sarwani, Sheldon L Holder

Cancer Biol Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
Sheldon L Holder, Sarki A Abdulkadir

Curr Cancer Drug Targets· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of topical vaginal androgens in a woman on the testosterone levels of her sexual partner with prostate cancer.
Mhd Y Al-Marrawi, Leah V Cream, Carol A Mallon, Sheldon Holder, Monika Joshi

J Clin Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis